MANHASSET, N.Y., Sept. 12, 2016 /PRNewswire-USNewswire/ -- In a study published today in the prestigious journal Nature
"Previous studies conducted at the Feinstein Institute found that the immune function could be controlled by neural mechanisms through the spleen, and with this study we were looking to identify triggers that could reach deeper into the smaller arteries to aid with conditions such as high blood pressure," said Kevin J. Tracey, MD, president and chief executive officer of the Feinstein Institute and one of lead authors of the Nature Biotechnology paper. "We found what we were looking for, and will develop this finding into new research that we hope will pave the way to new therapies that will improve the lives of millions."
Scientists from the Feinstein Institute, Karolinska Institutet in Stockholm, Sweden, University Health Network in Toronto, and York University in Toronto collaborated in making the discovery published in the Nature Biotechnology paper. Researchers at the Feinstein Institute, who are leaders in the field of bioelectronic medicine, have partnered with the Karolinska Institutet for the past 10 years. The Karolinska Institutet is one of the most-prestigious medical universities in the world and is the home of the Nobel Prize. Peder S. Olofsson, MD, PhD, worked at the Feinstein Institute between 2009 and 2015 and has since returned to the Karolinska Institute as founding director of its Center for Bioelectronic Medicine. The Feinstein Institute and Karolinska Institutet collaborate to help propel the field of bioelectronic medicine.
"Interdisciplinary collaborations in bioelectronic medicine offer an opportunity to improve understanding of little understood physiological mechanisms. This study, which focusesd on blood pressure regulation, represents one such advance," said Dr. Olofsson, corresponding author of the Nature Biotechnology paper.
The study was supported with grants from the National Institute of Health and the National Institute of General Medicine.
More Details about the Study:
A previous Feinstein Institute paper published in Science (Science 334, 98–101; 2011) describes that T-cells in the spleen express choline acetyltransferase (ChAT), which can affect immune function under the control of the vagus nerve. The research described in the recent Nature Biotechnology paper aimed to further examine these T-cells that synthesize via ChAT vasorelaxant acetylcholine, which affects blood pressure. When observing mice in this study, researchers observed that those without ChAT in their T-cells exhibited high blood pressure. This led to the conclusion that the source of acetylcholine that affects arterial pressure are these T-cells.
About the Feinstein Institute
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the 2,000 researchers and staff of the Feinstein are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/feinstein-institute-scientists-identify-previously-undiscovered-role-of-enzyme-in-regulating-blood-pressure-300326156.html
SOURCE Northwell Health
Subscribe to our Free Newsletters!
Proper understanding of waste collection, segregation and management is required to reduce the ...
Leukoplakia refers to a painless, raised white patch in the mouth that does not go away on rubbing, ...
Health insurance has emerged one of the fastest growing segments in the non-life insurance industry ...View All